Company profile: BioCat
1.1 - Company Overview
Company description
- Provider of specialized distribution of products and services to the life science research market, offering a wide portfolio of instruments and research reagents in genomics, proteomics, and cell biology for academia and the pharma and biotech industries.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to BioCat
Microarrays
HQ: United States
Website
- Description: Provider of microarray platforms and services for analyte testing, diagnostics, and personalized medicine, including pathway-focused gene expression arrays (MI PathArray), whole-genome microarrays (MI ReadyArray), DNA and protein/antibody arrays, assay development, and lab services for RNA profiling and microarray assays.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Microarrays company profile →
Enancio
HQ: France
Website
- Description: Provider of high-speed, efficient genomic data compression and decompression, complementing Illumina’s other informatics solutions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Enancio company profile →
BioLamina
HQ: Sweden
Website
- Description: Provider of cell culture matrices based on human recombinant laminins for primary cells and stem cell applications. Products include Biolaminin 521 LN and 521 MX for chemically defined, feeder-free self-renewal of human ES/iPS cells (LN: animal origin-free; MX: animal origin-free to the secondary level); 521 CTG for clinical studies and feeder-free culture of PSCs, MSCs, and progenitor cells; 111/121 LN as general attachment proteins; and 211 LN for tissue-specific cell growth and differentiation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BioLamina company profile →
Spindiag
HQ: Germany
Website
- Description: Provider of an easy-to-use, compact, automated point-of-care PCR system for broad, fast, and affordable pathogen detection. The Rhonda player with Rhonda disks detects infectious agents—including SARS-CoV-2, Influenza A/B, RSV, and MRSA—with results in under one hour; the SARS-CoV-2 disk supports direct swab insertion. The Rhonda app displays results for mobile use, and test outcomes can be transferred directly into patient records.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Spindiag company profile →
Circulomics
HQ: United States
Website
- Description: Provider of micro- and nanotechnology-driven solutions for nucleic acid sample preparation and long-read sequencing, offering Nanobind high molecular weight DNA extraction from plant, animal, and microbial samples, library preparation protocols, services for single chromosomal genome assemblies, and applications leveraging optical mapping for genome structure analysis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Circulomics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for BioCat
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to BioCat
2.2 - Growth funds investing in similar companies to BioCat
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for BioCat
4.2 - Public trading comparable groups for BioCat
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →